The impact of HPV vaccines and screening tests on cervical cancer prevention: A National Cancer Institute Science Writers' Seminar

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
  • Posted: September 21, 2010
NCI Press Office



Please join us for a science writers' seminar to discuss new research findings and future directions in HPV-related cancer research. Among the topics discussed will be the natural history of HPV and related cancers, advances in screening techniques and tools, the role of vaccines and microbicides in prevention, both nationally and internationally, and future research directions. The seminar will allow ample time for Q&A and interaction during the talks.


Mark Schiffman, M.D., Senior Investigator, Clinical Genetics Branch, NCI Division of Cancer Epidemiology and Genetics (DCEG): HPV and Cancer: Global Impact and Natural History of HPV and HPV-related Cancers

Diane Solomon, M.D., Acting Chief, Breast and Gynecologic Cancer Research Group, NCI Division of Cancer Prevention: The Evolution of Cervical Cancer Screening from Pap to HPV Testing

Allan Hildesheim, Ph.D., Chief, Infections and Immunoepidemiology Branch, DCEG: Efficacy of HPV Preventive Vaccines; Studies in Costa Rica and Beyond

John Schiller, Ph.D., Head, Neoplastic Disease Section, NCI Center for Cancer Research: Microbicides: Future Directions for Cancer Prevention


Tuesday, October 19, 2010: 9:00 a.m. – 11:30 a.m. (EDT)
Registration is at 8:45 a.m. Talks by experts begin at 9:00 a.m. Coffee and light refreshments offered at the start of the seminar and during the coffee break.


National Institutes of Health
NCI Director’s Conference Room, Building 31, Room 11A01. For reporters outside of the metro D.C. area, access via the Web at and dial-in for audio at 866-502-8312 (passcode= 836302).


For reporters, please register for the seminar by contacting the NCI Office of Media Relations at (301) 496-6641 or Space is limited.

Follow us on Twitter @NCIMedia and use the hash tag #NCISWS to discuss the session with other participants.

# # #